Results 21 to 30 of about 377,437 (162)

Use of Intravitreal Methotrexate Infusion in Complicated Retinal Detachment for Prevention of Proliferative Vitreoretinopathy in a Pilot Study

Cureus, 2021
Objective The objective of this pilot study was to evaluate the efficacy and safety of per-operative intravitreal methotrexate (MTX) infusion during vitrectomy in patients of retinal detachment (RD) with advanced grade proliferative vitreoretinopathy ...
S. Jahangir, Tehmina Jahangir, M. H. Ali, Q. Lateef, Uzma Hamza, Haroon Tayyab   +5 more
semanticscholar   +1 more source

Doxycycline Ameliorates the Severity of Experimental Proliferative Vitreoretinopathy in Mice

International Journal of Molecular Sciences, 2021
After successful surgeries for patients with rhegmatogenous retinal detachment, the most common cause of retinal redetachment is proliferative vitreoretinopathy (PVR), which causes severe vision impairment and even blindness worldwide.
Shun-Hua Chen, Yu-Jheng Lin, Li-Chiu Wang, Hsien-Yang Tsai, Chang-Hao Yang, Yu-Ti Teng, Sheng-Min Hsu   +6 more
semanticscholar   +1 more source

Outcomes and complications of primary rhegmatogenous retinal detachment repair with pars plana vitrectomy in young adults

International Journal of Retina and Vitreous, 2023
Background Scleral buckling has been the standard for rhegmatogenous retinal detachment repair in young patients given the typical lack of posterior vitreous detachment, phakic status, and lower risk of proliferative vitreoretinopathy. In older patients,
Venkatkrish M. Kasetty, Jennifer Aye, Nish Patel, Nitika Tripathi, Thomas Hessburg, Nitin Kumar, Uday R. Desai, Abdualrahman E. Hamad   +7 more
doaj   +1 more source

Comparison study of results of vitrectomy and vitrectomy with scleral buckling for the treatment of patients with rhegmatogenous retinal detachment at high risk proliferative vitreoretinopathy

Journal of Ophthalmology, 2017
he aim of our study was to analyze the effectiveness of vitrectomy and vitrectomy with scleral buckling in patients with a high risk of proliferative vitreoretinopathy.
L.A. Akhundova, M.I. Kerimov
doaj   +1 more source

Safety and Efficacy of Hypersonic Vitrectomy for Retinal Reattachment Surgery in Proliferative Vitreoretinopathies

Clinical Ophthalmology, 2022
Svenja Deuchler,1– 3 Julia Scholtz,1 Timo Knoch,4 Berthold Seitz,2 Frank H Koch1,3 1Study Centre, Augenzentrum Frankfurt, Frankfurt am Main, Hessen, Germany; 2Department of Ophthalmology, Saarland University Medical Center, Homburg, Saarland ...
Deuchler S, Scholtz J, Knoch T, Seitz B, Koch FH   +4 more
doaj  

Clinical study on Hypotony following blunt ocular trauma

International Journal of Ophthalmology, 2012
AIM: To evaluate the incidence and risk factors of hypotony in patients with blunt ocular trauma. METHODS: The medical records of 145 patients with blunt ocular trauma were reviewed. Hypotony was defined as an average intraocular pressure (IOP) of 5mmHg
Chun Ding, Jun Zeng
doaj   +1 more source

Inflammatory and Fibrogenic Factors in Proliferative Vitreoretinopathy Development

Translational Vision Science & Technology, 2020
Purpose Proliferative vitreoretinopathy (PVR) occurs in 5%–10% of rhegmatogenous retinal detachment cases and is the principle cause for failure of retinal reattachment surgery.
Rishika Chaudhary, R. Scott, G. Wallace, M. Berry, A. Logan, R. Blanch   +5 more
semanticscholar   +1 more source

The Outcomes of Recurrent Retinal Detachment Surgery and the Effects of the First Surgeon to the Final Outcomes

Boğaziçi Tıp Dergisi, 2020
INTRODUCTION[|]To evaluate the outcomes of vitreoretinal surgery in patients with recurrent retinal detachment (RD) and compare whether these outcomes differ regarding the surgeon who carried out the first surgery.[¤]METHODS[|]The medical records of the ...
Hatice Nur Tarakçıoğlu, Abdullah Özkaya   +1 more
doaj   +1 more source

Inflammatory mediators of proliferative vitreoretinopathy: hypothesis and review

International ophtalmology, 2020
Purpose To review the role of inflammatory mediators in proliferative vitreoretinopathy (PVR) development and the current treatment for PVR prevention. Methods A PubMed search was carried out using these keywords “PVR,” “inflammatory mediators,” “growth ...
Y. Dai, C. Dai, Tao Sun
semanticscholar   +1 more source

Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy

Mediators of Inflammation, 2004
PURPOSE: To investigate whether caffeic acid phenethyl ester (CAPE) and cortisone prevent proliferative vitreoretinopathy (PVR).
Yusuf Turkoz, Hamdi Er, Mehmet Borazan, Harun Yılmaz, Bülent Mızrak, Hakan Parlakpınar, Yılmaz Çigremis   +6 more
doaj   +1 more source